Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avricore Health (AVCRF) Operating Expenses (2016 - 2025)

Avricore Health has reported Operating Expenses over the past 12 years, most recently at $83922.0 for Q4 2025.

  • Quarterly Operating Expenses fell 26.41% to $83922.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $422113.7 through Dec 2025, up 11.44% year-over-year, with the annual reading at $334475.2 for FY2025, 73.85% down from the prior year.
  • Operating Expenses was $83922.0 for Q4 2025 at Avricore Health, down from $109586.7 in the prior quarter.
  • Over five years, Operating Expenses peaked at $407485.4 in Q3 2023 and troughed at $26738.7 in Q1 2022.
  • The 5-year median for Operating Expenses is $102268.6 (2024), against an average of $148007.5.
  • Year-over-year, Operating Expenses surged 913.89% in 2022 and then tumbled 84.16% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $39529.6 in 2021, then soared by 659.54% to $300244.8 in 2022, then rose by 5.88% to $317901.8 in 2023, then crashed by 64.13% to $114039.1 in 2024, then dropped by 26.41% to $83922.0 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Operating Expenses are $83922.0 (Q4 2025), $109586.7 (Q3 2025), and $102058.1 (Q2 2025).